A new cholesterol lowering injection drug has recently been approved by the FDA and is making it’s way to the market. This drug will be taken by injection and will cast over 14,000 a year. This price tag brings up the common discussion of how big pharmaceutical companies are charging outrageous prices for medicine.
“The first in a “revolutionary” new class of injected, cholesterol-lowering drugs has been approved by the Food and Drug Administration (FDA), but its price tag is likely to add to the growing debate overescalating medication costs. The drug, called Praluent, will cost about $14,600 a year — much higher than the $7,000 to $12,000 that some health-plan executives and Wall Street analysts had been expecting, according to the New York Times. It joins a number of new specialty drugs, for diseases such as cancer and hepatitis C, that come with eye-popping prices. Just this past week, more than 100 oncologists from the country’s top cancer centerscalled for curbs on the rapidly escalating price of cancer drugs. They noted that every new drug approved by the FDA in 2014 was priced at more than $120,000 per year.”
Full article here